Figure 3.
FMNT attenuates ox-LDL-induced viability inhibition in HUVECs. (a) HUVECs were treated with designated concentrations of FMNT for 24 h, followed cell viability determination. (b and c) HUVECs were treated with 40 μg/mL of ox-LDL for 24 h with or without 40 µM FMNT, followed by CCK-8 assay of cell viability (b) and EdU assay of cell proliferation (c). **P < 0.01, ***P < 0.001